It’s very tempting to pile into the stocks with the strongest positive momentum of the moment — they’ve proven themselves and could continue along this path. But in many cases, you could set yourself up for a bigger win if you look to quality companies that have seen their stocks stumble in recent times. This is because you’ll buy at a reasonable price and potentially win as the stock recovers and goes on to gain.
Two biotech stocks make perfect candidates for this sort of strategy right now. Each represents a bargain buy right now. It’s also important to note that these two players share a product, one that should start generating significant revenue in the quarters to come. Let’s take a close look at these two biotech stocks that are screaming buys in May.
This post originally appeared at The Motley Fool.